2019 Archive

Research

New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?

Melissa Hines, MD

HLH, a rare disorder of the immune system, is caused by a buildup of proteins responding to infection. Read about a new treatment that limits that buildup.

Research

Tumor microenvironment switches from homely to hostile when this process is turned off

Douglas R. Green, PhD

Researchers learn how this housekeeper for cancer cells turns into a cancer house killer. Learn how targeting LAP could promote an anti-tumor response and slow tumor growth.